CIK 0000926617
- Non-accelerated filer
- Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330595156
- Phone
- +1 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Gift SVP, Chief Science Officer gave 11,765 shares (gift)
- 4 Grant or award SVP, Chief Science Officer acquired 20,169 shares (grant or award)
- 4 Grant or award Director acquired 60,508 shares (grant or award)
- 4 Grant or award Director acquired 60,508 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 180,476 shares at an average $3.52 ($635,791)
- 4 Open-market buy VP-Chief Science Officer bought 250 shares at $0.43 ($106)
- 4 Open-market buy President and CEO bought 250 shares at $0.43 ($106)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 22 of 28 · 551 filings